Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Nevro’s comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...

Nevro’s HFX spinal cord stimulation platform (SCS) includes the Senza SCS system. It offers support services for chronic pain treatment of limbs and trunks, as well as painful diabetic neuropathy. The ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro. In February ... suffering from chronic pain,” said Dan Scavilla, president ...

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering ...